Bloginfo
May 2, 2024

SwiftDuct’s first clinical study, which was conducted at Galilee Medical Center, demonstrates that the company’s electrochemical navigation method has the potential to improve ERCP procedures and outcomes, marking an important milestone towards Fluoroscopy-Free ERCP cannulation. ERCP is a widely used procedure to diagnose and treat issues in the bile or pancreatic ducts. Sakhnin, Israel, May […]...

February 13, 2024

Or Yehuda, Israel and Raanana, Israel, February 13, 2024 — PatenSee, developer of a fistula monitoring system for dialysis patients, has entered into an agreement with Fresenius Medical Care, a leading global provider of dialysis services. Under the agreement, the parties will first collaborate in a joint, multi-center, pilot trial of PatenSee’s contactless monitoring system […]...

January 17, 2024

Enrollment to commence in Q1 2024 Or Yehuda, Israel, January 17, 2024 — Exero Medical’s prospective, blinded, multi-center study of xBar has been approved by the WCG. The study, expected to commence during Q1 2024 at several leading US and Israeli hospitals, will enroll about 190 patients undergoing colorectal resection.  It will evaluate the performance […]...

This website uses cookies

We use cookies to enhance your experience on our site. Visit our Privacy Policy and Terms and Conditions of Use to learn more. By using our site, you agree to our use of cookies.

Agree | Learn More
Subscribe to Newsletter